Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures Read more about Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures
Pharmacokinetics and Safety Study of Tapentadol for Postsurgical Pain in Children and Adolescents Read more about Pharmacokinetics and Safety Study of Tapentadol for Postsurgical Pain in Children and Adolescents
A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine Read more about A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD) Read more about To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF Read more about Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF
The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment Read more about The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment
Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder Read more about Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder
Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder Read more about Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD) Read more about Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)